SuperworthCabaletta Bio market cap CABA
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $249.2M
- Highest close in our data
- $1.1B
- Feb 2024
Cabaletta Bio is worth $249.2M at the close on Oct 23, 2026, at $1.47 a share.
That is up 10% over the last year and down 27% over five years.
Its highest close in our data was $1.1B in Feb 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $249.2M | $202.2M | $616.3M | +18% |
| 2025 | $210.8M | $55.8M | $330.2M | +88% |
| 2024 | $111.9M | $91.4M | $1.1B | −88% |
| 2023 | $972.7M | $205.4M | $972.7M | +262% |
| 2022 | $268.4M | $18.2M | $268.4M | +150% |
| 2021 | $107.4M | $107.4M | $366.9M | −64% |
| 2020 | $300.2M | $153.6M | $419.9M | −10% |
| 2019 | $332.2M | $192M | $332.2M | n/a |
Against its peers
Companies in Biotechnology nearest Cabaletta Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| CABACabaletta Bio | $249.2M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Cabaletta Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.